Thomas B Karasic, MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
3400 Civic Center Blvd
PCAM South Tower 10-102
Philadelphia, PA 19104
Office: 215-615-1594
Fax: 215-662-2432
Education:
BA (Chemistry and Biology)
Cornell University, 2008.
MD (Medicine)
Columbia University College of Physicians and Surgeons, 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Thomas B Karasic, Timothy J Brown, Charles Schneider, Ursina R Teitelbaum, Kim A Reiss, Tara C Mitchell, Ryan C Massa, Mark H O’Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi K Amaravadi, Peter J O’Dwyer: Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer. The Oncologist 2022 Notes: Accepted.

Timothy J. Brown, Arjun Gupta, Ramy Sedhom, Muhammad S. Beg, Thomas B. Karasic, Mark Yarchoan : Trends of Clinical Outcomes of Patients with Advanced Hepatocellular Carcinoma Treated with First-line Sorafenib in Randomized Controlled Trials. Gastrointestinal Tumors December 2021.

Eric Van Cutsem, Hans Prenen, Brant Delafontaine, Kristen R. Spencer, Tara C. Mitchell, Howard A. Burris, III, Nuria Kotecki, Rebecca Kristeleit, David J. Pinato, Solmaz Sahebjam, Donna M. Graham, Thomas Karasic, Jeannie Daniel, Kevin O’Hayer, Ryan Geschwindt, Sarina A. Piha-Paul : Phase 1 study of INCB086550, an oral PD-L1 inhibitor, in immune-checkpoint naive patients with advanced solid tumors. SITC Annual Meeting 2021 Nov 2021.

Kim A. Reiss, Rosemarie Mick, Mark H. O'Hara, Ursina Teitelbaum, Thomas B. Karasic, Charles Schneider, Stacy Cowden, Traci Southwell, Janae Romeo, Natallia Izgur, Zain M. Hannan, Rashmi Tondon, Katherine Nathanson, Robert H. Vonderheide, MD, DPhil1, Max M. Wattenberg, Gregory Beatty, MD, PhD, and Susan M. Domchek : Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2. Journal of Clinical Oncology May 2021.

Ravy K Vajravelu, Shivan J Mehta, Thomas B Karasic, Ronac Mamtani, Frank I Scott, James D Lewis: Understanding Characteristics of Who Undergoes Testing Is Crucial for the Development of Diagnostic Strategies to Identify Individuals at Risk for Early-age Onset Colorectal Cancer Gastroenterology 160(4): 993-998, Mar 2021.

Alexandra D Dreyfuss, Andrew R Barsky, E Paul Wileyto, Jennifer R Eads, John C Kucharczuk, Noel N Williams, Thomas B Karasic, James M Metz, Edgar Ben-Josef, John P Plastaras, Andrzej P Wojcieszynski : The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer. Cancer Medicine 10(4): 1275-1288, Feb 2021.

Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W. Valle, Chigusa Morizane, Thomas B. Karasic, Thomas A. Abrams, Junji Furuse, Robin Kate Kelley, Philippe A. Cassier, Heinz-Josef Klümpen, Nataliya V. Uboha, Amit Mahipal, Edith Mitchell, Eugene R. Ahn, Heung-Moon Chang, Kunihiro Masuda, Yaohua He, Karim A. Benhadji, John A. Bridgewater: Futibatinib in patients with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2. Cholangiocarcinoma Annual Meeting 2021 2021.

Teresa Macarulla, Victor Moreno, Li-Tzong Chen, Michael B. Sawyer, Lipika Goyal, Andres J. Muñoz Martín, Yang Sheng-Shun, Samuel Le Sourd, John Morris, Michael Fuchs, Thomas Benjamin Karasic, Yoon-Koo Kang, Wei-Peng Yong, Anand Selvaraj, Benoit Destenaves, Jianjun Alan Xiao, Ronald Gomez, Antonio Gualberto, J. Marc Marc Pipas, Richard S. Finn: Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC). ASCO Virtual Annual Meeting 2021 2021.

Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Chigusa Morizane, Juan W. Valle, Thomas B. Karasic, Thomas A. Abrams, Robin Kate Kelley, Philippe Cassier, Junji Furuse, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Yaohua He, Nital Soni, Karim A. Benhadji, John A. Bridgewater: Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1–4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements. AACR Virtual Annual Meeting 2021 2021.

Timothy J Brown, Thomas Benjamin Karasic, Charles John Schneider, Ursina R. Teitelbaum, Kim Anna Reiss, Tara C. Mitchell, Ryan Campbell Massa, Mark H. O'Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi K. Amaravadi, Peter J. O'Dwyer: Phase I trial of regorafenib, hydroxychloroquine, and entinostat in metastatic colorectal cancer. ASCO Virtual Annual Meeting 2021 2021.

back to top
Last updated: 03/24/2022
The Trustees of the University of Pennsylvania